Phase I Trial of Preoperative Chemoradiation Plus Sorafenib for High Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates

PURPOSE: We performed a phase I trial of the addition of sorafenib to a chemoradiotherapy regimen in patients with high-risk (intermediate/high grade, >5 cm) extremity soft tissue sarcoma (STS) undergoing limb salvage surgery. We conducted a correlative study of quantitative dynamic contrast-enha...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Meyer, Janelle M., Perlewitz, Kelly S., Hayden, James B., Doung, Yee-Cheen, Hung, Arthur Y., Vetto, John T., Pommier, Rodney F., Mansoor, Atiya, Beckett, Brooke R., Tudorica, Alina, Mori, Motomi, Holtorf, Megan L., Afzal, Aneela, Woodward, William J., Rodler, Eve T., Jones, Robin L., Huang, Wei, Ryan, Christopher W.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2013
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3869565/
https://ncbi.nlm.nih.gov/pubmed/24132922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1594
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια